|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/28/18 Usana Health Sciences Inc 10-K 12/30/17 82:10M Toppan Merrill-FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.28M
2: EX-21 Subsidiaries List HTML 45K
3: EX-23.1 Consent of Experts or Counsel HTML 24K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 29K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 29K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 24K
14: R1 Document And Entity Information HTML 52K
15: R2 Consolidated Balance Sheets HTML 85K
16: R3 Consolidated Balance Sheets (Parenthetical) HTML 32K
17: R4 Consolidated Statements Of Comprehensive Income HTML 92K
18: R5 Consolidated Statement Of Stockholders' Equity HTML 77K
19: R6 Consolidated Statements Of Cash Flows HTML 120K
20: R7 Summary Of Significant Accounting Policies HTML 176K
21: R8 Inventories HTML 49K
22: R9 Prepaid Expenses And Other Current Assets HTML 54K
23: R10 Income Taxes HTML 206K
24: R11 Property And Equipment HTML 87K
25: R12 Intangible Assets HTML 205K
26: R13 Other Current Liabilities HTML 60K
27: R14 Line Of Credit HTML 31K
28: R15 Commitments And Contingencies HTML 59K
29: R16 Equity Based Compensation HTML 180K
30: R17 Segment Information HTML 184K
31: R18 Quarterly Financial Results HTML 114K
32: R19 Earnings Per Share HTML 97K
33: R20 Related Party Transactions HTML 36K
34: R21 Valuation And Qualifying Accounts HTML 96K
35: R22 Summary Of Significant Accounting Policies HTML 250K
(Policy)
36: R23 Summary Of Significant Accounting Policies HTML 91K
(Tables)
37: R24 Inventories (Tables) HTML 49K
38: R25 Prepaid Expenses And Other Current Assets (Tables) HTML 54K
39: R26 Income Taxes (Tables) HTML 189K
40: R27 Property And Equipment (Tables) HTML 85K
41: R28 Intangible Assets (Tables) HTML 197K
42: R29 Other Current Liabilities (Tables) HTML 59K
43: R30 Commitments And Contingencies (Tables) HTML 41K
44: R31 Equity-Based Compensation (Tables) HTML 173K
45: R32 Segment Information (Tables) HTML 182K
46: R33 Quarterly Financial Results (Tables) HTML 112K
47: R34 Earnings Per Share (Tables) HTML 94K
48: R35 Summary Of Significant Accounting Policies HTML 121K
(Narrative) (Details)
49: R36 Summary Of Significant Accounting Policies HTML 38K
(Schedule Of Assets And Liabilities Measured At
Fair Value) (Details)
50: R37 Inventories (Details) HTML 34K
51: R38 Prepaid Expenses And Other Current Assets HTML 41K
(Details)
52: R39 Income Taxes (Narrative) (Details) HTML 69K
53: R40 Income Taxes (Schedule Of Income Tax Expense HTML 48K
(Benefit)) (Details)
54: R41 Income Taxes (Reconciliation Of Income Tax HTML 42K
Provision) (Details)
55: R42 Income Taxes (Schedule Of Deferred Taxes) HTML 83K
(Details)
56: R43 Property And Equipment (Details) HTML 76K
57: R44 Intangible Assets (Narrative) (Details) HTML 32K
58: R45 Intangible Assets (Schedule Of Goodwill) (Details) HTML 40K
59: R46 Intangible Assets (Schedule Of Finite And HTML 46K
Indefinite Lived Intangible Assets) (Details)
60: R47 Intangible Assets (Schedule Of Estimated HTML 39K
Amortization Expense) (Details)
61: R48 Other Current Liabilities (Details) HTML 47K
62: R49 Line Of Credit (Details) HTML 43K
63: R50 Commitments And Contingencies (Narrative) HTML 49K
(Details)
64: R51 Commitments And Contingencies (Schedule Of Minimum HTML 42K
Rental Payments For Operating Leases) (Details)
65: R52 Equity-Based Compensation (Narrative) (Details) HTML 93K
66: R53 Equity-Based Compensation (Schedule Of Remaining HTML 35K
Unrecognized Compensation Expense For Unvested
Awards) (Details)
67: R54 Equity-Based Compensation (Schedule Of Fair Value HTML 37K
Assumptions) (Details)
68: R55 Equity-Based Compensation (Schedule Of HTML 59K
Stock-Settled Stock Appreciation Rights Activity)
(Details)
69: R56 Equity-Based Compensation (Schedule Of Restricted HTML 40K
Stock Unit Activity) (Details)
70: R57 Equity-Based Compensation (Schedule Of Deferred HTML 43K
Stock Unit Activity) (Details)
71: R58 Segment Information (Narrative) (Details) HTML 27K
72: R59 Segment Information (Schedule Of Revenue HTML 31K
Percentage By Product) (Details)
73: R60 Segment Information (Schedule Of Revenues From HTML 44K
External Customers By Geographical Areas)
(Details)
74: R61 Segment Information (Schedule Of Long-Lived Assets HTML 40K
By Geographic Region) (Details)
75: R62 Segment Information (Consolidated Net Sales And HTML 38K
Long Lived Assets) (Details)
76: R63 Quarterly Financial Results (Summary Of Quarterly HTML 42K
Financial Information) (Details)
77: R64 Earnings Per Share (Schedule Of Earnings Per HTML 48K
Share) (Details)
78: R65 Related Party Transactions (Details) HTML 34K
79: R66 Valuation And Qualifying Accounts (Details) HTML 43K
81: XML IDEA XML File -- Filing Summary XML 142K
80: EXCEL IDEA Workbook of Financial Reports XLSX 97K
8: EX-101.INS XBRL Instance -- usna-20171230 XML 3.33M
12: EX-101.CAL XBRL Calculations -- usna-20171230_cal XML 218K
13: EX-101.DEF XBRL Definitions -- usna-20171230_def XML 412K
10: EX-101.LAB XBRL Labels -- usna-20171230_lab XML 1.15M
9: EX-101.PRE XBRL Presentations -- usna-20171230_pre XML 899K
11: EX-101.SCH XBRL Schema -- usna-20171230 XSD 162K
82: ZIP XBRL Zipped Folder -- 0001047469-18-001146-xbrl Zip 193K
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
The undersigned hereby certifies that the Annual Report on Form 10-K of USANA Health Sciences, Inc. for the period ended December 30, 2017 as filed February 28, 2018 with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of The Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of USANA Health Sciences, Inc.
|
|
|
|
Date: February 28, 2018 |
|
|
|
|
|
|
Chief Financial Officer |
|
|
(Principal Accounting and Financial Officer) |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/28/18 | None on these Dates | ||
| For Period end: | 12/30/17 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/29/18 SEC UPLOAD¶ 1/29/19 2:45K Usana Health Sciences Inc. 11/14/18 SEC UPLOAD¶ 1/29/19 2:48K Usana Health Sciences Inc. 10/23/18 SEC UPLOAD¶ 1/29/19 2:49K Usana Health Sciences Inc. |